ScienceMed®

Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: Umbrella review of published systematic reviews and meta-analyses

Cardiologia
Imagem de arquivo, ilustrativa — não é do estudo. Músculo cardíaco em corte longitudinal, com os discos intercalares, ao microscópio óptico. Berkshire Community College Bioscience Image Library · CC0 · Wikimedia Commons

Revisão sistemáticaNível 1 · Evidência consolidadaNutrition, metabolism, and cardiovascular diseases : NMCD8 fev 202511 citações

Salvar

Resumo original em inglês

O que aconteceu

Several systematic reviews/meta-analyses of observational studies have demonstrated associations between circulating trimethylamine-N-oxide (TMAO) and cardiovascular, cerebral, and renal diseases, including mortality. However, causal roles for TMAO in these diseases are controversial. Interventions are lacking to show whether lowering TMAO in clinical trials could reduce the risks of these diseases. TMAO could still serve as a prognostic marker for the mentioned outcomes, but investigating this potential role requires robust methodologies. We conducted a systematic search and critical evaluation of published systematic reviews/meta-analyses in the field.

O que encontraram

We identified 27 systematic reviews/meta-analyses on the association between TMAO and stroke (n = 7), cardiovascular disease including cause-specific and/or all-cause mortality (n = 14), and other related outcomes (n = 6). The majority of the systematic reviews/meta-analyses found higher blood TMAO concentrations in patients who were positive for the outcomes. Primary studies included populations with multiple risk factors for the given outcomes and did not sufficiently account for potential confounders. Prospective studies examining associations between baseline TMAO and subsequent disease outcomes in healthy populations were entirely absent. Furthermore, we identified serious flaws in methods, conduct and reporting in the majority of the published systematic reviews/meta-analyses, thus leading to critically low confidence in the results.

Por que isso importa

High quality systematic reviews/meta-analyses examining the associations between TMAO and cardiovascular or cerebral disease are needed to examine potential causal and/or predictive roles of TMAO in these diseases. This study is registered at the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42024534940).

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: Umbrella review of published systematic reviews and meta-analyses

Rima Obeid, Lorenz Mohr, Bryan A White, Gunnar H Heine, Insa Emrich, Juergen Geisel, R Colin Carter

Descritores MeSH

  • Cardiovascular Diseases
  • Kidney Diseases
  • Methylamines
  • Cerebrovascular Disorders
  • Risk Factors
  • Meta-Analysis as Topic
  • Biomarkers
  • Systematic Reviews as Topic
  • Risk Assessment
  • Cause of Death

Veja também